21 new cases of COVID-19 in Singapore, all imported


SINGAPORE: There were 21 new cases of COVID-19 in Singapore at noon on Thursday (April 8), the Ministry of Health (MOH) said.

All new infections have been imported and have been notified upon arrival in Singapore.

Five Singaporeans and a permanent resident returning from India and the United States were among the new cases reported on Thursday.

Three are student pass holders arriving from India and two more are work pass holders who have traveled from India and the Maldives.

Nine other cases are work permit holders from Bangladesh, India, Indonesia and Ukraine. Three of these cases are foreign domestic workers.

ALSO READ  Economists raise Singapore GDP growth forecast for 2021 to 5.8%: MAS survey

The remaining case is a short-term visitor’s pass holder who arrived from the Philippines for a work project in Singapore.

Another 24 cases were released from hospitals or community isolation facilities, bringing the total recoveries to 60,284.

There are 43 cases that are still in the hospital. Most are stable or improving, and one is in critical condition in the intensive care unit.

A total of 218 cases are isolated and treated in community facilities.

Overall, the number of new cases in the community fell from three the previous week to two last week, the health ministry said, adding that the number of unrelated cases in the community also fell from three. the previous week to two in the last week.

ALSO READ  Take a look: Face masks one year on: From filtered masks to surgical masks, which are best to wear?


A widely available and inexpensive drug used for the treatment of cancer could potentially be used in the treatment of COVID-19, according to a study by researchers in Singapore and the United States.

They found that the chemotherapy drug, called Topotecan, reduced the severity and death rates of infection with the virus that causes COVID-19, by suppressing inflammation in the lungs of laboratory animals.

The safety and efficacy of the treatment in humans will soon be evaluated at clinical sites around the world, the National University Cancer Institute in Singapore said, adding that its team had secured a research grant to conduct a phase clinical trial. 1 on Topotecan in COVID- 19 patients.

ALSO READ  Defense of lawyer who allegedly fled to Malaysia in millions missing case pleads for bail

READ: Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study

Singapore reported 60,575 cases of COVID-19 and 30 deaths on Thursday.

REPORT THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://TBEN.asia/telegram



Please enter your comment!
Please enter your name here